Lab-Grown lung tumors could personalize cancer care

NCT ID NCT05092009

Ongoing Knowledge-focused Sponsor: Maastricht Radiation Oncology Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study collects extra tissue and a small blood sample from people undergoing standard procedures for lung cancer. Researchers will use these samples to grow miniature versions of the tumors, called organoids, in the lab. The goal is to study how lung cancers grow and change, and to test which treatments might work best for each patient's unique tumor.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to study lung cancer in the lab and personalize treatment choices for patients.
What could go wrong: This is an early-stage, observational study focused on lab research, not a direct treatment. Growing organoids from patient samples may not always succeed, and findings may not immediately translate to patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Show contact details

Locations

MUMC+

Maastricht, 6229 HX, Netherlands
Maastricht Radiation Oncology (Maastro)

Maastricht, 6229 ET, Netherlands
Zuyderland Medical Center

Heerlen, 6419 PC, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.